GeneDx Holdings Corp.
announcedU=S+W/3W=S@11.50
WGS
Capital Structure & Economics
Trust Size$350,000,000
Unit Price$10.00
Warrant Coverage1/3
Sponsor Promote20%
Implied Equity Architecture
Capital Allocation Baseline
Trust (100.0%)
Implied Dilution Drag
33% Warrant Inclusion| Public Trust Allocation | $350,000,000 |
| Sponsor At-Risk Capital | N/A |
| Total Underwriting Discount | N/A |
| Trust Per Unit (Implied) | $10.00 |
| Sponsor Promote Allocation | 20% |
Deal Lifecycle
IPO PricedAug 14, 2020
Target AnnouncedJan 14, 2022
Maturation Wall
N/A
Announced Target / M&A
- Target CompanyGeneDx, Inc.
- Announcement Date2022-01-14
Board & Officers
- CEO
- Munib IslamOfficer
- Emily LeproustOfficer
- Officer
- Officer
- Director
- Director
Syndicate & Advisors
- LEAD
- FINANCIAL ADVISOR
- Perceptive Credit Holdings IV, LPAUDITOR
- TRANSFER AGENT
- Morgan Stanley, N.A.TRUSTEE
Interactive Deal Modeling
Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.